Secondary prevention for stroke after CAPRIE and ESPS-2. Opinion 1.
Davis
S M
SM
Donnan
G A
GA
D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000517:prevention & control*; D000077144:Clopidogrel; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D000077144:Clopidogrel; D013988:Ticlopidine